Details
- The only work to provide an accessible introduction to the interface between these two areas of law
- Fully updated to accommodate the immense legislative changes that have taken place since the first edition, including seminal cases such as Microsoft, IMS, Intel and Astra Zeneca
- Extended focus on the introduction of core concepts such as the definition of the relevant market and dominance
- Written by two leading academics in the field
New to this edition
- Includes new chapters on misuse (which includes a discussion of reverse patent settlements) and competition between competitors looking at technology pools and R&D Joint Ventures
- Includes a robust assessment of the EU Microsoft case and all recent developments in the pharmaceutical industry
Widely read and appreciated in its first edition by students, academics and junior practitioners, this was the first book to offer an accessible introduction to the interface between competition law and intellectual property rights.
Now fully updated, but retaining the accessible approach, it continues to represent an ideal gateway to this increasingly dynamic interface, offering a sound introduction to the topic based on thorough legal analysis. It provides a foundation to EU competition law rules as they relate to intellectual property rights, and explores how such a template can be applied to existing intellectual property rights and adapted to new technologies such as telecommunications and information technology. It demonstrates how, both under the EU law and as a matter of economic policy, EU competition law must provide a set of outer limits to, and a framework of rules which regulate, the exploitation and licensing of intellectual property rights.
A group of landmark cases since the first edition - the Microsoft case and its predecessor concerned with database rights, the IMS case - has extended the scope of Article 102 TFEU to a refusal to license interface codes. Article 102 has also been applied in the Astra Zeneca case to regulate the behaviour of pharmaceutical companies and the pharmaceutical sector has recently experienced a sectoral enquiry. Finally, the field of industrial standards, patent ambushes and FRAND obligations has become the subject of competition law scrutiny. Under Article 101 TFEU, the modernisation reforms and the new Technology Transfer Block Exemption Regulation 772/2004 together with the Technology Transfer Guidelines have quite radically reformed the method that lawyers must use when analysing the limits of clauses in intellectual property licensing. It requires greater economic understanding, offers less legal certainty but allows more flexibility than its predecessor. The book offers a comprehensive insight to these new developments in a textbook style ideal for those approaching the subject for the first time, or a useful reference for those with more experience.
Readership: Academics, students and practitioners of competition law and intellectual property law.
I General Introduction
1: Introduction
2: The Relationship between Intellectual Property Rights and competition law
II Article 102
3: Article 102 and Intellectual Propert Rights
4: The Relevant Market and Intellectual Property Rights
5: The Concept of Dominance and Intellectual Property Rights
6: The Concept of Abuse and Intellectual Property Rights
7: Refusal to Supply and License and Intellectual Property Rights
8: Tying
9: Excessive Pricing and Intellectual Property Rights
10: Exclusionary Pricing Policies: Discriminatory Pricing, Rebates and Discounts
11: Exclusionary Pricing:Predatory Pricing and Margin Squeeze
III Article 101 and Intellectual Property Liocensing in a Modernized Setting
12: Introduction: Intelletual Property Rights Licensing and Competition Policy Generally
13: The Structure of Article 101 TFEU and IP Licensing Agreements
14: The Judicial Concept of Restriction of Competition and IPR Licensing
15: The Technology Transfer: Block Exemption Regulation and Technology Transfer Agreement Guidelines
16: The Regulation of Territorial Restraints in Intellectual Property Right Licensing Agreements under Article 101 TFEU
17: The Regulation of Non-Territorial Restraints in Licensing Agreements
18: Technology Pools, Industrial Standards, and TTBER
19: Remedies
20: Conclusions
Steven Anderman, Professor of Law, The University of Essex, and Hedvig Schmidt, Lecturer in Law, The University of Southampton
Steven Anderman is Professor of Law in the Department of Law at University of Essex, UK and Guest Professor at Stockholm University School of Law. He has worked as Expert on Competition Law for the Economic and Social Committee of the EU from 1984-2004 and has advised both the Singapore (2004) and Chinese (2007) Governments on the IP consequences of their competition laws.
Dr Hedvig Schmidt is Lecturer in EU Law in the School of Law at the University of Southampton, UK.
Review(s) from previous edition
"Using clear and concise language, it ties together legislation, case law and the author's personal views into a whole, with the purpose of demonstrating that competition law should continue policing the activities of IP right owners - International Journal of Law and Information Technology
"This is a highly stimulating book, by an expert in competition law " - NLJ Book Review Supplement
"He approaches the subject-matter clearly from the viewpoint of a competition lawyer, rather than an I.P. lawyer ... Professor Anderman's thesis is well-reasoned and argued ... an invaluable addition to any library and an interesting exposition of the law " - Robyn Durie, Linklaters and Paines, London, EIPR, vol 21, issue 6, 1999
